High rates of ofloxacin resistance in Mycobacterium tuberculosis among both new and previously treated patients in Tamil Nadu, South India.
Periodic drug resistance surveillance provides useful information on trends of drug resistance and effectiveness of tuberculosis (TB) control measures. The present study determines the prevalence of drug resistance among new sputum smear positive (NSP) and previously treated (PT) pulmonary TB patien...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC4349813?pdf=render |
| _version_ | 1811220514750857216 |
|---|---|
| author | N Selvakumar Vanaja Kumar S Balaji S Prabuseenivasan R Radhakrishnan Gomathi Sekar V Chandrasekaran T Kannan Aleyamma Thomas S Arunagiri Puneet Dewan Soumya Swaminathan |
| author_facet | N Selvakumar Vanaja Kumar S Balaji S Prabuseenivasan R Radhakrishnan Gomathi Sekar V Chandrasekaran T Kannan Aleyamma Thomas S Arunagiri Puneet Dewan Soumya Swaminathan |
| author_sort | N Selvakumar |
| collection | DOAJ |
| description | Periodic drug resistance surveillance provides useful information on trends of drug resistance and effectiveness of tuberculosis (TB) control measures. The present study determines the prevalence of drug resistance among new sputum smear positive (NSP) and previously treated (PT) pulmonary TB patients, diagnosed at public sector designated microscopy centers (DMCs) in the state of Tamil Nadu, India. In this single-stage cluster-sampling prevalence survey, 70 of 700 DMCs were randomly selected using a probability-proportional to size method. A cluster size of 24 for NSP and a varying size of 0 to 99 for PT cases were fixed for each selected DMC. Culture and drug susceptibility testing was done on Lowenstein-Jensen medium using the economic variant of proportion sensitivity test for isoniazid (INH), rifampicin (RMP), ofloxacin (OFX) and kanamycin (KAN). Human Immunodeficiency Virus (HIV) status was collected from patient records. From June 2011 to August 2012, 1524 NSP and 901 PT patients were enrolled. Any RMP resistance and any INH resistance were observed in 2.6% and 15.1%, and in 10.4% and 30% respectively in NSP and PT cases. Among PT patients, multi drug resistant TB (MDR-TB) was highest in the treatment failure (35%) group, followed by relapse (13%) and treatment after default (10%) groups. Extensively drug resistant TB (XDRTB) was seen in 4.3% of MDR-TB cases. Any OFX resistance was seen in 10.4% of NSP, 13.9% of PT and 29% of PT MDR-TB patients. The HIV status of the patient had no impact on drug resistance levels. RMP resistance was present in 2.6% of new and 15.1% of previously treated patients in Tamil Nadu. Rates of OFX resistance were high among NSP and PT patients, especially among those with MDR-TB, a matter of concern for development of new treatment regimens for TB. |
| first_indexed | 2024-04-12T07:43:11Z |
| format | Article |
| id | doaj.art-31e211c02c9f45a583a0c47e67d1e30e |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-04-12T07:43:11Z |
| publishDate | 2015-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-31e211c02c9f45a583a0c47e67d1e30e2022-12-22T03:41:46ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01103e011742110.1371/journal.pone.0117421High rates of ofloxacin resistance in Mycobacterium tuberculosis among both new and previously treated patients in Tamil Nadu, South India.N SelvakumarVanaja KumarS BalajiS PrabuseenivasanR RadhakrishnanGomathi SekarV ChandrasekaranT KannanAleyamma ThomasS ArunagiriPuneet DewanSoumya SwaminathanPeriodic drug resistance surveillance provides useful information on trends of drug resistance and effectiveness of tuberculosis (TB) control measures. The present study determines the prevalence of drug resistance among new sputum smear positive (NSP) and previously treated (PT) pulmonary TB patients, diagnosed at public sector designated microscopy centers (DMCs) in the state of Tamil Nadu, India. In this single-stage cluster-sampling prevalence survey, 70 of 700 DMCs were randomly selected using a probability-proportional to size method. A cluster size of 24 for NSP and a varying size of 0 to 99 for PT cases were fixed for each selected DMC. Culture and drug susceptibility testing was done on Lowenstein-Jensen medium using the economic variant of proportion sensitivity test for isoniazid (INH), rifampicin (RMP), ofloxacin (OFX) and kanamycin (KAN). Human Immunodeficiency Virus (HIV) status was collected from patient records. From June 2011 to August 2012, 1524 NSP and 901 PT patients were enrolled. Any RMP resistance and any INH resistance were observed in 2.6% and 15.1%, and in 10.4% and 30% respectively in NSP and PT cases. Among PT patients, multi drug resistant TB (MDR-TB) was highest in the treatment failure (35%) group, followed by relapse (13%) and treatment after default (10%) groups. Extensively drug resistant TB (XDRTB) was seen in 4.3% of MDR-TB cases. Any OFX resistance was seen in 10.4% of NSP, 13.9% of PT and 29% of PT MDR-TB patients. The HIV status of the patient had no impact on drug resistance levels. RMP resistance was present in 2.6% of new and 15.1% of previously treated patients in Tamil Nadu. Rates of OFX resistance were high among NSP and PT patients, especially among those with MDR-TB, a matter of concern for development of new treatment regimens for TB.http://europepmc.org/articles/PMC4349813?pdf=render |
| spellingShingle | N Selvakumar Vanaja Kumar S Balaji S Prabuseenivasan R Radhakrishnan Gomathi Sekar V Chandrasekaran T Kannan Aleyamma Thomas S Arunagiri Puneet Dewan Soumya Swaminathan High rates of ofloxacin resistance in Mycobacterium tuberculosis among both new and previously treated patients in Tamil Nadu, South India. PLoS ONE |
| title | High rates of ofloxacin resistance in Mycobacterium tuberculosis among both new and previously treated patients in Tamil Nadu, South India. |
| title_full | High rates of ofloxacin resistance in Mycobacterium tuberculosis among both new and previously treated patients in Tamil Nadu, South India. |
| title_fullStr | High rates of ofloxacin resistance in Mycobacterium tuberculosis among both new and previously treated patients in Tamil Nadu, South India. |
| title_full_unstemmed | High rates of ofloxacin resistance in Mycobacterium tuberculosis among both new and previously treated patients in Tamil Nadu, South India. |
| title_short | High rates of ofloxacin resistance in Mycobacterium tuberculosis among both new and previously treated patients in Tamil Nadu, South India. |
| title_sort | high rates of ofloxacin resistance in mycobacterium tuberculosis among both new and previously treated patients in tamil nadu south india |
| url | http://europepmc.org/articles/PMC4349813?pdf=render |
| work_keys_str_mv | AT nselvakumar highratesofofloxacinresistanceinmycobacteriumtuberculosisamongbothnewandpreviouslytreatedpatientsintamilnadusouthindia AT vanajakumar highratesofofloxacinresistanceinmycobacteriumtuberculosisamongbothnewandpreviouslytreatedpatientsintamilnadusouthindia AT sbalaji highratesofofloxacinresistanceinmycobacteriumtuberculosisamongbothnewandpreviouslytreatedpatientsintamilnadusouthindia AT sprabuseenivasan highratesofofloxacinresistanceinmycobacteriumtuberculosisamongbothnewandpreviouslytreatedpatientsintamilnadusouthindia AT rradhakrishnan highratesofofloxacinresistanceinmycobacteriumtuberculosisamongbothnewandpreviouslytreatedpatientsintamilnadusouthindia AT gomathisekar highratesofofloxacinresistanceinmycobacteriumtuberculosisamongbothnewandpreviouslytreatedpatientsintamilnadusouthindia AT vchandrasekaran highratesofofloxacinresistanceinmycobacteriumtuberculosisamongbothnewandpreviouslytreatedpatientsintamilnadusouthindia AT tkannan highratesofofloxacinresistanceinmycobacteriumtuberculosisamongbothnewandpreviouslytreatedpatientsintamilnadusouthindia AT aleyammathomas highratesofofloxacinresistanceinmycobacteriumtuberculosisamongbothnewandpreviouslytreatedpatientsintamilnadusouthindia AT sarunagiri highratesofofloxacinresistanceinmycobacteriumtuberculosisamongbothnewandpreviouslytreatedpatientsintamilnadusouthindia AT puneetdewan highratesofofloxacinresistanceinmycobacteriumtuberculosisamongbothnewandpreviouslytreatedpatientsintamilnadusouthindia AT soumyaswaminathan highratesofofloxacinresistanceinmycobacteriumtuberculosisamongbothnewandpreviouslytreatedpatientsintamilnadusouthindia |